Hikma Pharmaceuticals USA INC. recalls Ciprofloxacin Tablets
- Published
- 11 Nov 2026
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9929-50
Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01
- Brand / company
- Hikma Pharmaceuticals USA INC.
- Codes / lots
- Lot# CA083A Exp. 12/31/2026 Lot# CA084A Exp. 12/31/2026 Lot# CA085A Exp. 12/31/2026 | Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026
- Distribution
- US Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 11 Nov 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.